Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate versus propofol for postoperative recovery after thoracoscopic lung cancer surgery
ChiCTR2500101483Phase 4Not yet recruiting
- Sponsor
- Jining First People's Hospital
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in bronchial carcinoma comparing Remimazolam group with Propofol group (2 arms). Primary endpoint: Quality of recovery. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2500101483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101483.